Alnylam Pharmaceuticals, Inc. (ALNY): Price and Financial Metrics
Alnylam Pharmaceuticals, Inc. (ALNY)
Today's Latest Price: $131.84 USD
2.46 (-1.83%)
Updated Oct 23 4:00pm
Add ALNY to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
ALNY Stock Summary
- With a one year PEG ratio of 422.91, Alnylam Pharmaceuticals Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 92.01% of US stocks.
- With a price/sales ratio of 45.85, Alnylam Pharmaceuticals Inc has a higher such ratio than 95.55% of stocks in our set.
- Revenue growth over the past 12 months for Alnylam Pharmaceuticals Inc comes in at 241.39%, a number that bests 97.17% of the US stocks we're tracking.
- If you're looking for stocks that are quantitatively similar to Alnylam Pharmaceuticals Inc, a group of peers worth examining would be GNTX, MXIM, FGEN, BMRN, and AMPH.
- Visit ALNY's SEC page to see the company's official filings. To visit the company's web site, go to www.alnylam.com.
ALNY Stock Price Chart Interactive Chart >
ALNY Price/Volume Stats
| Current price | $131.84 | 52-week high | $167.33 |
| Prev. close | $134.30 | 52-week low | $83.06 |
| Day low | $130.72 | Volume | 528,900 |
| Day high | $134.75 | Avg. volume | 699,849 |
| 50-day MA | $135.87 | Dividend yield | N/A |
| 200-day MA | $132.32 | Market Cap | 15.29B |
Alnylam Pharmaceuticals, Inc. (ALNY) Company Bio
Alnylam Pharmaceuticals is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. The company was founded in 2002 and is based in Cambridge, Massachusetts.
Loading social stream, please wait...